Potentiating the antibacterial effect of silver nanospheres by surface-capping with chlorhexidine gluconate
Source abstract
Abstract
In this work, the commercial polyvinylpyrrolidone (PVP)-capped silver nanospheres (Ag-NSP) were surface decorated with chlorhexidine gluconate (CHXg) for potentiating the antibacterial properties of Ag-NSP. Different formulations of CHXg-loaded Ag-NSP (Ag-NSP/CHXg) were prepared by varying the incubation times (0.5, 1.5, and 3 h). A thorough characterization of Ag-NSP/CHXg nanospheres has been carried out by dynamic light scattering (DLS), transmission electron microscopy (TEM), energy-dispersive surface elemental composition spectral analysis (SEM/EDX), Fourier transform infrared spectroscopy (FTIR), percentage (%) CHXg loading efficiency (LE), in vitro CHXg and Ag+ ion release, antibacterial/biofilm inhibition assay, and human mesenchymal stem cells (hMSCs) cytotoxicity evaluation. DLS measured nanospheres to be <160 nm and indicated that CHXg treatment drastically shifted the surface charge from negative to high positive values, with homogenous distribution. TEM revealed spherical Ag-NSP/CHXg nanospheres with a clearly visible surface coating of CHXg. FTIR confirmed association of CHXg with Ag-NSP nanospheres, whereas SEM/EDX data verified presence of spectral peaks specific to silver (Ag), CHXg, and PVP. The %LE gradually increased with increasing incubation times. In vitro CHXg release exhibited a bi-phasic fashion showing maximum release of ~74.83 ± 20.67% from Ag-NSP/CHXg-3h at 14 days. A slow release of Ag+ ions was detected; however, the surface decoration of Ag-NSP substantially hampered/restricted the liberation of ions. Agar well diffusion, MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H–tetrazolium), and crystal violet assay suggested good antibacterial/antibiofilm activity of Ag-NSP/CHXg that correlated with the increasing %LE of nanospheres. hMSCs cytotoxicity study showed low toxicity properties of all nanosphere formulations, except for Ag-NSP/CHXg-3h, affecting the cell viability at all proposed concentrations and exposure time points. CHXg accentuated the antibacterial properties of Ag-NSP.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Ahlberg S et al (2014) PVP-coated, negatively charged silver nanoparticles: a multi-center study of their physicochemical characteristics, cell culture and in vivo experiments. Beilstein journal of nanotechnology 5:1944–196510.3762/bjnano.5.205 ↗
2. Ansari MA, Khan HM, Khan AA, Cameotra SS, Pal R (2014) Antibiofilm efficacy of silver nanoparticles against biofilm of extended spectrum β-lactamase isolates of Escherichia coli and Klebsiella pneumoniae. Appl Nanosci 4:859–86810.1007/s13204-013-0266-1 ↗
3. Ashajyothi C, Oli AK, Prabhurajeshwar C (2014) Potential bactericidal effect of silver nanoparticles synthesised from Enterococcus species. Orient J Chem 30:1253–126210.13005/ojc/300341 ↗
4. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA (2007) Effect of silver on burn wound infection control and healing: review of the literature. Burns 33:139–14810.1016/j.burns.2006.06.010 ↗
5. Behra R et al (2013) Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface 10:2013039610.1098/rsif.2013.0396 ↗
6. Betancourt-Galindo R et al. (2012) Encapsulation of silver nanoparticles in a polystyrene matrix by miniemulsion polymerization and its antimicrobial activity ISRN Nanotechnology 201210.5402/2012/186851 ↗
7. Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME (2012) Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol 78:2768–277410.1128/AEM.06513-11 ↗
8. Cavassin ED et al (2015) Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria. Journal of nanobiotechnology 13:110.1186/s12951-015-0120-6 ↗
9. Chudobova D, Maskova D, Kopel P, Merlos Rodrigo M, Kizek R (2013) The effect of silver ions and silver nanoparticles on Staphylococcus aureus. Formatex
10. Dakal TC, Kumar A, Majumdar RS, Yadav V (2016) Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol 710.3389/fmicb.2016.01831 ↗
11. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM (2010) Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol 45:283–28710.1021/es1034188 ↗
12. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ (2005) Interaction of silver nanoparticles with HIV-1. Journal of nanobiotechnology 3:610.1186/1477-3155-3-6 ↗
13. Faria G, Celes MR, De Rossi A, Silva LAB, Silva JS, Rossi MA (2007) Evaluation of chlorhexidine toxicity injected in the paw of mice and added to cultured l929 fibroblasts. J Endod 33:715–72210.1016/j.joen.2006.12.023 ↗
14. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R (2010) Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomed Nanotechnol Biol Med 6:103–10910.1016/j.nano.2009.04.006 ↗
15. Ge L, Li Q, Wang M, Ouyang J, Li X, Xing MM (2014) Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomedicine 9:2399
16. Greulich C, Kittler S, Epple M, Muhr G, Köller M (2009) Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbeck's Arch Surg 394:495–50210.1007/s00423-009-0472-1 ↗
17. Harshiny M, Matheswaran M, Arthanareeswaran G, Kumaran S, Rajasree S (2015) Enhancement of antibacterial properties of silver nanoparticles–ceftriaxone conjugate through Mukia maderaspatana leaf extract mediated synthesis. Ecotoxicol Environ Saf 121:135–14110.1016/j.ecoenv.2015.04.041 ↗
18. Huynh KA, Chen KL (2011) Aggregation kinetics of citrate and polyvinylpyrrolidone coated silver nanoparticles in monovalent and divalent electrolyte solutions. Environ Sci Technol 45:5564–557110.1021/es200157h ↗
19. Hwang IS, Hwang JH, Choi H, Kim K-J, Lee DG (2012) Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J Med Microbiol 61:1719–172610.1099/jmm.0.047100-0 ↗
20. Ibrahim MA, Neo J, Esguerra RJ, Fawzy AS (2015) Characterization of antibacterial and adhesion properties of chitosan-modified glass ionomer cement. J Biomater Appl:088532821558967210.1177/0885328215589672 ↗
21. ISO E (2009) 10993–5. Biological evaluation of medical devices-part 5: tests for in vitro cytotoxicity Geneva: International Organization for Standardization
22. Jose M, Sakthivel M (2014) Synthesis and characterization of silver nanospheres in mixed surfactant solution. Mater Lett 117:78–8110.1016/j.matlet.2013.11.020 ↗
23. Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S (2010) Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces 79:340–34410.1016/j.colsurfb.2010.04.014 ↗
24. Kim JS et al (2007) Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 3:95–10110.1016/j.nano.2006.12.001 ↗
25. Kittler S, Greulich C, Köller M, Epple M (2009) Synthesis of PVP-coated silver nanoparticles and their biological activity towards human mesenchymal stem cells. Mater Werkst 40:258–26410.1002/mawe.200800437 ↗
26. Lang N, Brecx MC (1986) Chlorhexidine digluconate—an agent for chemical plaque control and prevention of gingival inflammation. J Periodontal Res 21:74–8910.1111/j.1600-0765.1986.tb01517.x ↗
27. Lessa FCR, Aranha AMF, Nogueira I, Giro EMA, Hebling J, Costa CAS (2010) Toxicity of chlorhexidine on odontoblast-like cells. J Appl Oral Sci 18:50–5810.1590/S1678-77572010000100010 ↗
28. Li YC, Kuan YH, Lee TH, Huang FM, Chang YC (2014) Assessment of the cytotoxicity of chlorhexidine by employing an in vitro mammalian test system. Journal of Dental Sciences 9:130–13510.1016/j.jds.2013.02.011 ↗
29. Liau S, Read D, Pugh W, Furr J, Russell A (1997) Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterialaction of silver ions. Lett Appl Microbiol 25:279–28310.1046/j.1472-765X.1997.00219.x ↗
30. Liu J, Sonshine DA, Shervani S, Hurt RH (2010) Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 4:6903–691310.1021/nn102272n ↗
31. López-García J, Lehocký M, Humpolíček P, Sáha P (2014) HaCaT keratinocytes response on antimicrobial atelocollagen substrates: extent of cytotoxicity, cell viability and proliferation. Journal of functional biomaterials 5:43–5710.3390/jfb5020043 ↗
32. Lu Z, Rong K, Li J, Yang H, Chen R (2013) Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J Mater Sci Mater Med 24:1465–147110.1007/s10856-013-4894-5 ↗
33. McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Gilbert P (2003) Effects of a chlorhexidine gluconate-containing mouthwash on the vitality and antimicrobial susceptibility of in vitro oral bacterial ecosystems. Appl Environ Microbiol 69:4770–477610.1128/AEM.69.8.4770-4776.2003 ↗
34. Monteiro DR et al (2013) Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. Mycoses 56:672–68010.1111/myc.12093 ↗
35. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16:234610.1088/0957-4484/16/10/059 ↗
36. Negreanu Pârjol T et al (2011) Cu (II) and zinc (II) complex compounds with biguanides aromatic derivatives: synthesis, characterization, biological activity. Sci Study Res Chem Chem Eng Biotech Food Industry 12:127–140
37. Niska K, Knap N, Kędzia A, Jaskiewicz M, Kamysz W, Inkielewicz-Stepniak I (2016) Capping agent-dependent toxicity and antimicrobial activity of silver nanoparticles: an in vitro study. Concerns about potential application in dental practice. Int J Med Sci 13:77210.7150/ijms.16011 ↗
38. Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712–172010.1128/AEM.02218-06 ↗
39. Pérez-Díaz MA et al (2015) Silver nanoparticles with antimicrobial activities against Streptococcus mutans and their cytotoxic effect. Mater Sci Eng C 55:360–36610.1016/j.msec.2015.05.036 ↗
40. Ren W et al (2012) Lanthanide ion-doped GdPO 4 nanorods with dual-modal bio-optical and magnetic resonance imaging properties. Nano 4:3754–3760
41. Reshad M, Nesbit M, Petrie A, Setchell D (2009) Chlorhexidine gluconate mouthwashes as a surfactant for addition-reaction silicone impressions. Eur J Prosthodont Restor Dent 17:2–8
42. Sari E, Birinci I (2007) Microbiological evaluation of 0.2% chlorhexidine gluconate mouth rinse in orthodontic patients. The Angle Orthodontist 77:881–88410.2319/080506-320.1 ↗
43. Schlinkert P et al (2015) The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types. Journal of nanobiotechnology 13:110.1186/s12951-014-0062-4 ↗
44. Sethi M et al (2014) Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity. Nano 6:2321–2327
45. Stensberg MC, Wei Q, McLamore ES, Porterfield DM, Wei A, Sepúlveda MS (2011) Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine 6:879–89810.2217/nnm.11.78 ↗
46. Sun Y, Gates B, Mayers B, Xia Y (2002) Crystalline silver nanowires by soft solution processing. Nano Lett 2:165–16810.1021/nl010093y ↗
47. Vivekanandan K, Raj KG, Kumaresan S, Pandi M (2012) Biosynthesis of silver nanoparticle activity against bacterial strain, cephalexin antibiotic synergistic activity. International Journal of Current Science 4:1–7
48. Wani MY, Hashim MA, Nabi F, Malik MA (2011) Nanotoxicity: dimensional and morphological concerns. Advances in Physical Chemistry 201110.1155/2011/450912 ↗
49. Wong KK (2012) Silver nanoparticles in medicine: is the panacea here nanomedicine: nanotechnology. Biol Med 8:935–940
50. Yah CS, Simate GS (2015) Nanoparticles as potential new generation broad spectrum antimicrobial agents. DARU Journal of Pharmaceutical Sciences 23:110.1186/s40199-015-0089-6 ↗
51. Zhang T, Wang L, Chen Q, Chen C (2014) Cytotoxic potential of silver nanoparticles. Yonsei Med J 55:283–29110.3349/ymj.2014.55.2.283 ↗